NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»03/09/2009 [Company watch]
China Aoxing Submits Cough Medicine for Approval

China Aoxing Pharmaceutical Company (CAXG.OB), which specializes in the strictly regulated sector of narcotic and pain medications, has submitted its application for SFDA approval of Codeine Phosphate, an oral solution for the treatment of acute moderate to severe cough. China Aoxing expects to launch this product in China in 2010, assuming the regulatory review goes well.

 
China Aoxing Pharmaceutical Company (CAXG.OB), which specializes in the strictly regulated sector of narcotic and pain medications, has submitted its application for SFDA approval of Codeine Phosphate, an oral solution for the treatment of acute moderate to severe cough. China Aoxing expects to launch this product in China in 2010, assuming the regulatory review goes well. As a Class III New Medicine – which means that China Aoxing’s product is the first example in China of a drug approved elsewhere in the world – the product is eligible for three years of market exclusivity. China Aoxing said the market for cough medications in China is about $2 billion per year and growing at a 10% rate annually. With annual revenues of just under $12 million, China Aoxing needs a boost to its sales to become profitable. American Oriental Bioengineering (AOB) owns a 38% stake in China Aoxing.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.